Back
Historic TAILORx Breast Cancer Trial Reaches Patient Accrual Goal
MVCC was just notified of a press release about the TAILORx trial reaching its patient accrual goal. Locally, the MVCC participated in this landmark breast cancer trial and we await study findings. Approximately 81 women were enrolled to the TAILORx trial through the MVCC program in Omaha and Lincoln.
For more information and to view the press release, please follow the link provided by the Coalition of Cancer Cooperative Groups
